| ŽÁČKOVÁ, Daniela, Hana KLAMOVÁ, Michael DOUBEK, Zdeněk POSPÍŠIL, Dana DVOŘÁKOVÁ, Tomáš JURČEK, Jana MORAVCOVÁ, Kateřina MACHOVÁ POLÁKOVÁ, Jana RULCOVÁ, Blanka DOBEŠOVÁ, Jana RYŠAVÁ, Petr CETKOVSKÝ, Filip RÁZGA a Jiří MAYER. Efficacy and Safety of Imatinib in the First Line Chronic Myeloid Leukemia (CML) Treatment. An Analysis of a Comprehensive Population-Based Database. In Haematologica/The Hematology Journal. 2009;94(s2):346. 2009. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1169377,
author = {Žáčková, Daniela and Klamová, Hana and Doubek, Michael and Pospíšil, Zdeněk and Dvořáková, Dana and Jurček, Tomáš and Moravcová, Jana and Machová Poláková, Kateřina and Rulcová, Jana and Dobešová, Blanka and Ryšavá, Jana and Cetkovský, Petr and Rázga, Filip and Mayer, Jiří},
booktitle = {Haematologica/The Hematology Journal. 2009;94(s2):346.},
language = {eng},
title = {Efficacy and Safety of Imatinib in the First Line Chronic Myeloid Leukemia (CML) Treatment. An Analysis of a Comprehensive Population-Based Database.},
year = {2009}
}
TY - CONF
ID - 1169377
AU - Žáčková, Daniela - Klamová, Hana - Doubek, Michael - Pospíšil, Zdeněk - Dvořáková, Dana - Jurček, Tomáš - Moravcová, Jana - Machová Poláková, Kateřina - Rulcová, Jana - Dobešová, Blanka - Ryšavá, Jana - Cetkovský, Petr - Rázga, Filip - Mayer, Jiří
PY - 2009
TI - Efficacy and Safety of Imatinib in the First Line Chronic Myeloid Leukemia (CML) Treatment. An Analysis of a Comprehensive Population-Based Database.
ER -
ŽÁČKOVÁ, Daniela, Hana KLAMOVÁ, Michael DOUBEK, Zdeněk POSPÍŠIL, Dana DVOŘÁKOVÁ, Tomáš JURČEK, Jana MORAVCOVÁ, Kateřina MACHOVÁ POLÁKOVÁ, Jana RULCOVÁ, Blanka DOBEŠOVÁ, Jana RYŠAVÁ, Petr CETKOVSKÝ, Filip RÁZGA a Jiří MAYER. Efficacy and Safety of Imatinib in the First Line Chronic Myeloid Leukemia (CML) Treatment. An Analysis of a Comprehensive Population-Based Database. In \textit{Haematologica/The Hematology Journal. 2009;94(s2):346.}. 2009.
|
